These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


215 related items for PubMed ID: 12370756

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Surgical outcome of intraductal papillary mucinous neoplasms of the pancreas.
    Nakagohri T, Kinoshita T, Konishi M, Takahashi S, Gotohda N.
    Ann Surg Oncol; 2007 Nov; 14(11):3174-80. PubMed ID: 17694416
    [Abstract] [Full Text] [Related]

  • 23. Immunohistochemical study of genetic alterations in intraductal and invasive ductal tumors of the pancreas.
    Islam HK, Fujioka Y, Tomidokoro T, Sugiura H, Takahashi T, Kondo S, Katoh H.
    Hepatogastroenterology; 2001 Nov; 48(39):879-83. PubMed ID: 11462947
    [Abstract] [Full Text] [Related]

  • 24. Differential roles of alterations of p53, p16, and SMAD4 expression in the progression of intraductal papillary-mucinous tumors of the pancreas.
    Sasaki S, Yamamoto H, Kaneto H, Ozeki I, Adachi Y, Takagi H, Matsumoto T, Itoh H, Nagakawa T, Miyakawa H, Muraoka S, Fujinaga A, Suga T, Satoh M, Itoh F, Endo T, Imai K.
    Oncol Rep; 2003 Nov; 10(1):21-5. PubMed ID: 12469138
    [Abstract] [Full Text] [Related]

  • 25. Comparison of K-ras point mutation distributions in intraductal papillary-mucinous tumors and ductal adenocarcinoma of the pancreas.
    Kitago M, Ueda M, Aiura K, Suzuki K, Hoshimoto S, Takahashi S, Mukai M, Kitajima M.
    Int J Cancer; 2004 Jun 10; 110(2):177-82. PubMed ID: 15069678
    [Abstract] [Full Text] [Related]

  • 26. The K-ras mutation pattern in pancreatic ductal adenocarcinoma usually is identical to that in associated normal, hyperplastic, and metaplastic ductal epithelium.
    Lüttges J, Schlehe B, Menke MA, Vogel I, Henne-Bruns D, Klöppel G.
    Cancer; 1999 Apr 15; 85(8):1703-10. PubMed ID: 10223563
    [Abstract] [Full Text] [Related]

  • 27. Clinical significance of frozen section analysis during resection of intraductal papillary mucinous neoplasm: should a positive pancreatic margin for adenoma or borderline lesion be resected additionally?
    Nara S, Shimada K, Sakamoto Y, Esaki M, Kosuge T, Hiraoka N.
    J Am Coll Surg; 2009 Nov 15; 209(5):614-21. PubMed ID: 19854402
    [Abstract] [Full Text] [Related]

  • 28. Progressive genomic alterations in intraductal papillary mucinous tumours of the pancreas and morphologically similar lesions of the pancreatic ducts.
    Soldini D, Gugger M, Burckhardt E, Kappeler A, Laissue JA, Mazzucchelli L.
    J Pathol; 2003 Apr 15; 199(4):453-61. PubMed ID: 12635136
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Intraductal carcinosarcoma with a heterologous mesenchymal component originating in intraductal papillary-mucinous carcinoma (IPMC) of the pancreas with both carcinoma and osteosarcoma cells arising from IPMC cells.
    Okamura J, Sekine S, Nara S, Ojima H, Shimada K, Kanai Y, Hiraoka N.
    J Clin Pathol; 2010 Mar 15; 63(3):266-9. PubMed ID: 20203229
    [Abstract] [Full Text] [Related]

  • 33. Clonality and field cancerization in intraductal papillary-mucinous tumors of the pancreas.
    Izawa T, Obara T, Tanno S, Mizukami Y, Yanagawa N, Kohgo Y.
    Cancer; 2001 Oct 01; 92(7):1807-17. PubMed ID: 11745253
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Clinical significance of p53, K-ras and DCC gene alterations in the stage I-II colorectal cancers.
    Akkiprik M, Ataizi-Celikel C, Düşünceli F, Sönmez O, Gulluoglu BM, Sav A, Ozer A.
    J Gastrointestin Liver Dis; 2007 Mar 01; 16(1):11-7. PubMed ID: 17410283
    [Abstract] [Full Text] [Related]

  • 38. Intraductal papillary-mucinous tumors of the pancreas.
    Kubosawa H, Uehara T, Watanabe Y, Urashima T, Matsubara H, Asano T, Ochiai T.
    Hepatogastroenterology; 2004 Mar 01; 51(59):1489-94. PubMed ID: 15362784
    [Abstract] [Full Text] [Related]

  • 39. Molecular events including p53 and k-ras alterations in the in vitro progression of a human colorectal adenoma cell line to an adenocarcinoma.
    Williams AC, Browne SJ, Yeudal WA, Paterson IC, Marshall CJ, Lane DP, Paraskeva C.
    Oncogene; 1993 Nov 01; 8(11):3063-72. PubMed ID: 8414507
    [Abstract] [Full Text] [Related]

  • 40. PIK3CA mutations in intraductal papillary mucinous neoplasm/carcinoma of the pancreas.
    Schönleben F, Qiu W, Ciau NT, Ho DJ, Li X, Allendorf JD, Remotti HE, Su GH.
    Clin Cancer Res; 2006 Jun 15; 12(12):3851-5. PubMed ID: 16778113
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 11.